Ticker Details
RAPT Therapeutics, Inc.
IPO Date:	October 28, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.68B
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.72 | 3.93%
Avg Daily Range (30 D):	$0.03 | 0.05%
Avg Daily Range (90 D):	$0.74 | 2.21%

Institutional Daily Volume
Avg Daily Volume:	.5M
Avg Daily Volume (30 D):	.63M
Avg Daily Volume (90 D):	1.69M

Trade Size
Avg Trade Size (Sh.):	107
Avg Trade Size (Sh.) (30 D):	370
Avg Trade Size (Sh.) (90 D):	227

Institutional Trades
Total Institutional Trades:	1,730
Avg Institutional Trade:	$1.91M
Avg Institutional Trade (30 D):	$.95M
Avg Institutional Trade (90 D):	$2.39M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.72M
Avg Closing Trade (30 D):	$6.04M
Avg Closing Trade (90 D):	$2.96M
Avg Closing Volume:	17.06K

News

Feb 25, 2026 @ 12:22 PM GSK Expands Pipeline With $950 Million Pulmonary H... Source: Vandana Singh

Feb 19, 2026 @ 11:30 PM Halper Sadeh LLC is Investigating Whether RAPT, CT... Source: Halper Sadeh Llc

Feb 19, 2026 @ 9:48 PM $HAREHOLDER ALERT: The M&A Class Action Firm Encou... Source: Monteverde & Associates Pc

Feb 2, 2026 @ 10:49 PM Halper Sadeh LLC Reminds Shareholders of RAPT, PEN... Source: Halper Sadeh Llc

Jan 28, 2026 @ 7:23 PM $HAREHOLDER ALERT: The M&A Class Action Firm Is In... Source: Prnewswire

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$10.67	$-.65	$-.65
Diluted EPS	$10.67	$-.65	$-.65
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-105.64M	$-17.58M	$-17.64M
Operating Income / Loss	$-112.64M	$-19.37M	$-19.54M
Cost of Revenue
Net Cash Flow	$.03M	$-3.96M	$-127.85M
PE Ratio